86 related articles for article (PubMed ID: 25837847)
1. Thymopoietin Beta and Gamma Isoforms as a Potential Diagnostic Molecular Marker for Breast Cancer: Preliminary Data.
Marrero-Rodríguez D; Taniguchi-Ponciano K; Lopez-Sleman J; Romero-Morelos P; Mendoza-Rodríguez M; Garcia I; Huerta-Padilla V; Mantilla A; Duarte A; Piña P; Rodriguez-Esquivel M; Lopez-Romero R; Parrazal-Romero J; Tobias-Alonso S; Jimenez-Vega F; Alvarez-Blanco M; Salcedo M
Pathol Oncol Res; 2015 Sep; 21(4):1045-50. PubMed ID: 25837847
[TBL] [Abstract][Full Text] [Related]
2.
Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
[TBL] [Abstract][Full Text] [Related]
3. Structure and mapping of the human thymopoietin (TMPO) gene and relationship of human TMPO beta to rat lamin-associated polypeptide 2.
Harris CA; Andryuk PJ; Cline SW; Mathew S; Siekierka JJ; Goldstein G
Genomics; 1995 Jul; 28(2):198-205. PubMed ID: 8530026
[TBL] [Abstract][Full Text] [Related]
4. On the role of thymopoietins in cell proliferation. Immunochemical evidence for new members of the human thymopoietin family.
Weber PJ; Eckhard CP; Gonser S; Otto H; Folkers G; Beck-Sickinger AG
Biol Chem; 1999 Jun; 380(6):653-60. PubMed ID: 10430029
[TBL] [Abstract][Full Text] [Related]
5. The characterization and localization of the mouse thymopoietin/lamina-associated polypeptide 2 gene and its alternatively spliced products.
Berger R; Theodor L; Shoham J; Gokkel E; Brok-Simoni F; Avraham KB; Copeland NG; Jenkins NA; Rechavi G; Simon AJ
Genome Res; 1996 May; 6(5):361-70. PubMed ID: 8743987
[TBL] [Abstract][Full Text] [Related]
6. The neurofibromin 1 type I isoform predominance characterises female population affected by sporadic breast cancer: preliminary data.
Marrero D; Peralta R; Valdivia A; De la Mora A; Romero P; Parra M; Mendoza N; Mendoza M; Rodriguez D; Camacho E; Duarte A; Castelazo G; Vanegas E; Garcia I; Vargas C; Arenas D; Jimenez F; Salcedo M
J Clin Pathol; 2012 May; 65(5):419-23. PubMed ID: 22412049
[TBL] [Abstract][Full Text] [Related]
7. Depletion of thymopoietin inhibits proliferation and induces cell cycle arrest/apoptosis in glioblastoma cells.
Zhang L; Wang G; Chen S; Ding J; Ju S; Cao H; Tian H
World J Surg Oncol; 2016 Oct; 14(1):267. PubMed ID: 27756319
[TBL] [Abstract][Full Text] [Related]
8. A method for identifying discriminative isoform-specific peptides for clinical proteomics application.
Zhang F; Chen JY
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):522. PubMed ID: 27557076
[TBL] [Abstract][Full Text] [Related]
9. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
Adams M; Jones JL; Walker RA; Pringle JH; Bell SC
Cancer Res; 2002 Jun; 62(11):3289-97. PubMed ID: 12036947
[TBL] [Abstract][Full Text] [Related]
10. Protein arginine methyltransferase 6-dependent gene expression and splicing: association with breast cancer outcomes.
Dowhan DH; Harrison MJ; Eriksson NA; Bailey P; Pearen MA; Fuller PJ; Funder JW; Simpson ER; Leedman PJ; Tilley WD; Brown MA; Clarke CL; Muscat GE
Endocr Relat Cancer; 2012 Aug; 19(4):509-26. PubMed ID: 22673335
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin-c is a selective marker of breast cancer.
Mirza M; Shaughnessy E; Hurley JK; Vanpatten KA; Pestano GA; He B; Weber GF
Int J Cancer; 2008 Feb; 122(4):889-97. PubMed ID: 17960616
[TBL] [Abstract][Full Text] [Related]
12. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
13. Relative expression of hMena11a and hMenaINV splice isoforms is a useful biomarker in development and progression of human breast carcinoma.
Tanaka N; Yoshida H; Suzuki Y; Harigaya K
Int J Oncol; 2014 Nov; 45(5):1921-8. PubMed ID: 25109497
[TBL] [Abstract][Full Text] [Related]
14. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
[TBL] [Abstract][Full Text] [Related]
15. Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration.
Pignatelli J; Goswami S; Jones JG; Rohan TE; Pieri E; Chen X; Adler E; Cox D; Maleki S; Bresnick A; Gertler FB; Condeelis JS; Oktay MH
Sci Signal; 2014 Nov; 7(353):ra112. PubMed ID: 25429076
[TBL] [Abstract][Full Text] [Related]
16. p63 expression in benign and malignant breast lesions.
Stefanou D; Batistatou A; Nonni A; Arkoumani E; Agnantis NJ
Histol Histopathol; 2004 Apr; 19(2):465-71. PubMed ID: 15024707
[TBL] [Abstract][Full Text] [Related]
17. Network-based approach to identify principal isoforms among four cancer types.
Ma J; Wang J; Ghoraie LS; Men X; Haibe-Kains B; Dai P
Mol Omics; 2019 Apr; 15(2):117-129. PubMed ID: 30720033
[TBL] [Abstract][Full Text] [Related]
18. Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer.
Davies MP; Barraclough DL; Stewart C; Joyce KA; Eccles RM; Barraclough R; Rudland PS; Sibson DR
Int J Cancer; 2008 Jul; 123(1):85-8. PubMed ID: 18386815
[TBL] [Abstract][Full Text] [Related]
19. BigH3 protein expression as a marker for breast cancer.
Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue.
Yang T; Zhang JS; Massa SM; Han X; Longo FM
Mol Carcinog; 1999 Jun; 25(2):139-49. PubMed ID: 10365916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
